Structure of b-AP15
CAS No.: 1009817-63-3
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
b-AP15 is an inhibitor of the ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCHL5) and ubiquitin-specific-processing protease 14 (USP14). In purified 19S proteasomes, b-AP15 can inhibit DUB activity with an IC50 of 2.1 μM.
Synonyms: NSC 687852
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1009817-63-3 |
Formula : | C22H17N3O6 |
M.W : | 419.39 |
SMILES Code : | O=C1/C(CN(C(C=C)=O)C/C1=C\C2=CC=C([N+]([O-])=O)C=C2)=C/C3=CC=C([N+]([O-])=O)C=C3 |
Synonyms : |
NSC 687852
|
MDL No. : | MFCD26142662 |
InChI Key : | GFARQYQBWJLZMW-JYFOCSDGSA-N |
Pubchem ID : | 5351435 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
RT4 | up to 2000 nM | 24 hours | Induced ER stress and apoptosis | Mol Ther Oncolytics. 2022 Aug 5;26:387-398. |
IMR-32 | 107.8 nM (IC50) | 72 hours | Inhibits cell proliferation and induces apoptosis | Mol Cancer Ther. 2019 Jun;18(6):1045-1056. |
LAN-6 | 127.8 nM (IC50) | 72 hours | Inhibits cell proliferation and induces apoptosis | Mol Cancer Ther. 2019 Jun;18(6):1045-1056. |
MelJuSo UbG76V-YFP cells | 1 µM | 1-3 hours | To study the effect of b-AP15 on proteasome function, it was found that b-AP15 inhibited proteasome function and led to cell death. | Antioxid Redox Signal. 2014 Dec 10;21(17):2271-85. |
HeLa cells | 10 µM | 2 hours | Immunoblot analysis showed that b-AP15 induced the formation of high molecular weight complexes with USP14. | J Med Chem. 2020 Apr 9;63(7):3756-3762. |
UMSCC1 cells | 250 nM | 24 hours | B-AP15 significantly inhibited the growth and colony formation capacity of UMSCC1 cells. | Cell Death Differ. 2023 May;30(5):1382-1396. |
BFTC905 | up to 2000 nM | 24 hours | Induced ER stress and apoptosis | Mol Ther Oncolytics. 2022 Aug 5;26:387-398. |
T24 | up to 2000 nM | 24 hours | Induced ER stress and apoptosis | Mol Ther Oncolytics. 2022 Aug 5;26:387-398. |
T24/R | up to 2000 nM | 24 hours | Induced ER stress and apoptosis | Mol Ther Oncolytics. 2022 Aug 5;26:387-398. |
Monocyte-derived dendritic cells | 10 nM, 100 nM, 500 nM, 1000 nM | 24 hours | Comparative analysis of effects of bortezomib and b-AP15 on dendritic cell phenotype and function, finding that b-AP15 had no compromising effects on these DC features. | Neoplasia. 2019 Jul;21(7):653-664. |
MCF-7 | 0.5, 1, 2, 5 µM | 24, 48, 72 hours | To evaluate the effect of b-AP15 on the growth of ER+ breast cancer cells, results showed that b-AP15 significantly inhibited cell viability. | Oncogenesis. 2018 Sep 24;7(9):75. |
T47D | 0.5, 1, 2, 5 µM | 24, 48, 72 hours | To evaluate the effect of b-AP15 on the growth of ER+ breast cancer cells, results showed that b-AP15 significantly inhibited cell viability. | Oncogenesis. 2018 Sep 24;7(9):75. |
PK-15 cells | 0–1 µM | 24–48 hours | To evaluate the inhibitory effect of b-AP15 on PRV-GFP proliferation, results showed that b-AP15 significantly inhibited PRV-GFP proliferation. | Autophagy. 2022 Aug;18(8):1801-1821. |
3D4/21 cells | 0–1 µM | 24–48 hours | To evaluate the inhibitory effect of b-AP15 on PRV-GFP proliferation, results showed that b-AP15 significantly inhibited PRV-GFP proliferation. | Autophagy. 2022 Aug;18(8):1801-1821. |
HNSCC cells | 250 nM | 48 hours | B-AP15 significantly reduced the proliferation and survival of HNSCC cells and induced apoptosis. | Cell Death Differ. 2023 May;30(5):1382-1396. |
SU-DHL-4 | 0.205 µM | 48 hours | B-AP15 inhibited the proliferation and induced apoptosis in GCB-DLBCL cells. | J Exp Clin Cancer Res. 2019 Nov 6;38(1):453. |
SU-DHL-2 | 0.296 µM | 48 hours | B-AP15 inhibited the proliferation and induced apoptosis in ABC-DLBCL cells. | J Exp Clin Cancer Res. 2019 Nov 6;38(1):453. |
RKO | 1-5 µM | 48 hours | B-AP15 significantly reduced the viability of RKO cells, with an IC50 value of 1.649 μM. | Acta Pharmacol Sin. 2023 Dec;44(12):2537-2548. |
RKO-R | 1-5 µM | 48 hours | B-AP15 significantly reduced the viability of RKO-R cells, with an IC50 value of 0.987 μM. | Acta Pharmacol Sin. 2023 Dec;44(12):2537-2548. |
HCT-15 | 1-5 µM | 48 hours | B-AP15 significantly reduced the viability of HCT-15 cells, with an IC50 value of 1.453 μM. | Acta Pharmacol Sin. 2023 Dec;44(12):2537-2548. |
HCT-15R | 1-5 µM | 48 hours | B-AP15 significantly reduced the viability of HCT-15R cells, with an IC50 value of 0.858 μM. | Acta Pharmacol Sin. 2023 Dec;44(12):2537-2548. |
HCT116 colon carcinoma cells | 1 µM | 6 hours | To study the effect of b-AP15 on gene expression in HCT116 cells, it was found that b-AP15 induced the expression of genes related to oxidative stress, ER stress, and heat shock. | Antioxid Redox Signal. 2014 Dec 10;21(17):2271-85. |
KMBC cells | 13 nM | 72 hours | Evaluate the sensitivity of b-AP15 in low BAP1 expressing cells, results showed increased sensitivity in KMBC cells with low BAP1 expression | Mol Cancer. 2017 Jan 25;16(1):22. |
HuCCT1 cells | 1.9 µM | 72 hours | Evaluate the sensitivity of b-AP15 in high BAP1 expressing cells, results showed lower sensitivity in HuCCT1 cells with high BAP1 expression | Mol Cancer. 2017 Jan 25;16(1):22. |
HAP1 BAP1 KO cells | 9 nM | 72 hours | Evaluate the sensitivity of b-AP15 in BAP1 knockout cells, results showed increased sensitivity in HAP1 BAP1 KO cells | Mol Cancer. 2017 Jan 25;16(1):22. |
HAP1 WT cells | 38 nM | 72 hours | Evaluate the sensitivity of b-AP15 in wild-type cells, results showed lower sensitivity in HAP1 WT cells | Mol Cancer. 2017 Jan 25;16(1):22. |
HeLa cells | 20 mM | B-AP15 increased the levels of ubiquitinated proteins in cells and led to a 2- to 2.5-fold stimulation of proteasomal peptidase activity. | Proc Natl Acad Sci U S A. 2022 Jun 21;119(25):e2122482119. | |
HCT116 colon cancer cells | 1 µM | Assess the cytotoxicity of b-AP15 on colon cancer cells | J Med Chem. 2020 Dec 24;63(24):15075-15093. |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Nude mice | Colon cancer xenograft model | Intraperitoneal injection | 100 mg/kg | Daily | Evaluate the antitumor activity of EF24 in colon cancer xenograft model | J Med Chem. 2020 Dec 24;63(24):15075-15093. |
Nude mice | HNSCC tumor xenograft model | Subcutaneous injection | 5 mg/kg | Multiple times per week for 2 weeks | B-AP15 as a monotherapy or in combination with radiation significantly delayed tumor growth and enhanced survival. | Cell Death Differ. 2023 May;30(5):1382-1396. |
Nude mice | NGP and SH-SY5Y xenograft models | Intraperitoneal injection | 5 mg/kg | Once daily for two weeks | Inhibits tumor growth and induces tumor cell apoptosis | Mol Cancer Ther. 2019 Jun;18(6):1045-1056. |
Nude mice | SU-DHL-4 and SU-DHL-2 cell xenograft models | Intraperitoneal injection | 5 mg/kg/day | Once daily for 11 days | B-AP15 significantly inhibited the growth of GCB- and ABC-DLBCL xenograft models. | J Exp Clin Cancer Res. 2019 Nov 6;38(1):453. |
Nude mice | CML xenograft model | Intraperitoneal injection | 5 mg/kg/day | Once daily until the tumor volume reached 1500 mm³ | B-AP15 significantly inhibited tumor growth in the CML xenograft model and reduced tumor volume and weight. | Clin Transl Med. 2022 Sep;12(9):e1038 |
Mice | Subcutaneous xenograft model | Intraperitoneal injection | 7.5 mg/kg | Thrice a week for 4 weeks | The combination of b-AP15 and cisplatin is superior to cisplatin monotherapy against UC in vivo | Mol Ther Oncolytics. 2022 Aug 5;26:387-398. |
Mice | PRV infection model | Intraperitoneal injection | 8 mg/kg | Every two days for 10 days | To evaluate the protective effect of b-AP15 on PRV infection in vivo, results showed that b-AP15 significantly reduced the mortality of PRV-infected mice and inhibited PRV replication. | Autophagy. 2022 Aug;18(8):1801-1821. |
Nude mice | RKO and RKO-R xenograft models | Intraperitoneal injection | 8 mg/kg/d | Once daily, continuous treatment | B-AP15 significantly suppressed the growth of RKO and RKO-R xenograft tumors without significantly affecting mouse body weight. | Acta Pharmacol Sin. 2023 Dec;44(12):2537-2548. |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.92mL 2.38mL 1.19mL |
23.84mL 4.77mL 2.38mL |
Tags: b-AP15 | NSC 687852 | NSC687852 | NSC-687852 | Deubiquitinase | Apoptosis | DUBs |UCHL5 Inhibitor | Usp14 Inhibitor | Ubiquitin C-terminal Hydrolase L5 | Ubiquitin-specific protease 14 | ubiquitin-proteasome system | DUB inhibitor | UCH37 | 1009817-63-3
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL